IDH1 and cancer: Among the oncogenic mutations reported to alter cancer cell metabolism, mutations in isocitrate dehydrogenase (IDH), which normally catalyses the oxidative decarboxylation of isocitrate to α-ketoglutarate (αKG), have attracted particular attention1,2.